- Advertise
- Contact Us
- Editorial Info
- Contribute
- Terms and Conditions
- Privacy Policy
- Do not sell my Personal Information
© 2022 MJH Life Sciences™ and Rheumatology Network. All rights reserved.
Juvenile Arthritis
Secukinumab Receives Positive CHMP Opinion for Expansion in Childhood Arthritic Conditions
May 20, 2022
The Committee for Medicinal Products for Human Use (CHMP) issues a positive opinion to expand Novartis secukinumab indication to enthesitis-related arthritis (ERA) and juvenile psoriatic arthritis (JPsA).
Janet E McDonagh, MD, FRCP: Juvenile Idiopathic Arthritis Age Delays in Rheumatological Care
May 06, 2022
Janet E McDonagh, MD, FRCP, discusses the study “The Role of Age in Delays to Rheumatological Care in Juvenile Idiopathic Arthritis.”
Celiac Disease More Prevalent in Patients With Juvenile Idiopathic Arthritis
April 26, 2022
“Understanding the extent of the co-occurrence and identifying factors associated with an increased susceptibility could be relevant to implement case-finding strategies in specific at-risk populations," investigators stated.
Joyce Chang, MD, MSCE: Racial Disparities in Children With Systemic Lupus Erythematosus
April 21, 2022
Joyce C. Chang MD, MSCE, discusses the racial disparities in renal outcomes for hospitalized children with systemic lupus erythematosus.
Adverse Experiences Negatively Impact Symptomology of Childhood Rheumatic Disease
March 30, 2022
Chronic stressors may play an important role in the development of chronic pain, leading to excess cortisol production and disruption to the body's sympathetic and parasympathetic systems.
Childhood Rheumatic Disease Negatively Impacts Standardized Test Scores
March 24, 2022
Limited physical function, fatigue, mental health issues (resulting from chronic disease), and medication issues can further affect the ability of children with rheumatic disease from performing well in school.
Karen Onel, MD: Updates in JIA Treatment Guidelines, Unmet Needs in Pediatric Rheumatology
March 15, 2022
Karen Onel, MD, one of the lead investigators of the ACR's recent JIA treatment guidelines updates, explains important changes, treating patients with glucocorticoids, and the continued unmet needs in pediatric rheumatology.
Daniel J. Lovell, MD, MPH: JIA Treatment and Management Guidelines
March 11, 2022
Daniel J. Lovell, MD, MPH, explains the recent ACR guidelines updates regarding the treatment and management of juvenile idiopathic arthritis and the clinical significance of the changes.
American College of Rheumatology Revises Guidelines for Treatment of Juvenile Idiopathic Arthritis
March 04, 2022
The American College of Rheumatology (ACR) has published guidance regarding the management of juvenile idiopathic arthritis, with emphasis placed on the treatment of systemic JIA and oligoarthritis, as well as non-pharmacologic therapies.
Improvements in Telehealth May Better Treat Pediatric Rheumatic Diseases
February 02, 2022
As telehealth is an emerging and rapidly changing form of pediatric rheumatology care, engaging patients, caregivers, and rheumatologists will help streamline care to improve satisfaction and overall experience.